14Aug

[Comment] At last, a randomised controlled trial of apomorphine infusion

For most medications, positive findings from large randomised controlled trials herald regulatory approval and subsequent marketing. Not so for apomorphine infusion, which arrived two decades ago as a treatment for Parkinson's disease, following publication of a relatively small open-label study.1 Previously used as an emetic, an opiate addiction remedy, an aphrodisiac, and even as a plot element for an Agatha Christie tale,2 subcutaneous apomorphine infusion eventually became widely used for the treatment of Parkinson's disease.

Ander nieuws

20May

[Review] CSF and blood biomarkers for Parkinson’s disease

In the management of Parkinson's disease, reliable diagnostic and prognostic biomarkers are urg...

naar nieuwsitem

20May

[Comment] A new step towards targeting tau

Progressive supranuclear palsy is a rare neurodegenerative disease characterised by an axial parkins...

naar nieuwsitem

22Apr

Parkinson’s disease patient: ‘I can walk… it’s really helped me’

Parkinson's disease patient Gail Jardine can walk more freely after having a spinal implant fit...

naar nieuwsitem